GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $38.10 $43.42 Thursday, 18th Apr 2024 CLDX stock ended at $38.53. This is 2.78% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $38.31 to a day high of $39.80.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2021-03-19 $24.76 $26.11 $24.45 $25.09 941 038
2021-03-18 $24.75 $25.62 $24.27 $24.99 823 631
2021-03-17 $23.25 $25.36 $23.25 $24.96 339 997
2021-03-16 $25.28 $25.28 $22.42 $24.07 452 096
2021-03-15 $25.47 $25.57 $24.35 $24.99 254 339
2021-03-12 $26.03 $26.35 $24.36 $25.38 514 946
2021-03-11 $26.74 $27.26 $25.85 $26.28 594 978
2021-03-10 $27.17 $27.73 $24.92 $26.25 420 315
2021-03-09 $26.73 $28.54 $26.50 $26.77 416 938
2021-03-08 $26.69 $29.39 $25.95 $26.20 553 073
2021-03-05 $25.25 $26.30 $22.62 $26.21 528 614
2021-03-04 $25.69 $26.64 $24.18 $25.20 640 162
2021-03-03 $29.90 $29.94 $26.51 $26.52 457 881
2021-03-02 $28.63 $30.17 $28.50 $29.91 397 238
2021-03-01 $27.44 $28.50 $27.44 $28.19 423 923
2021-02-26 $27.58 $28.02 $26.46 $27.08 423 466
2021-02-25 $27.98 $28.79 $27.04 $27.51 678 306
2021-02-24 $27.59 $28.05 $26.80 $27.75 564 324
2021-02-23 $28.71 $28.71 $25.84 $27.71 821 369
2021-02-22 $27.73 $29.30 $26.48 $28.25 895 954
2021-02-19 $27.25 $28.12 $26.92 $27.89 574 920
2021-02-18 $25.56 $26.71 $25.07 $26.65 853 188
2021-02-17 $24.89 $26.07 $24.51 $25.60 952 107
2021-02-16 $24.69 $25.37 $24.06 $25.25 735 394
2021-02-12 $23.50 $24.96 $23.30 $24.30 448 878
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT